Li Ka shing-backed cancer drug developer delays Hong Kong IPO

Li Ka shing-backed cancer drug developer delays Hong Kong IPO

Hong Kong. Photo by SHUJA ZED on Unsplash

CK Hutchison Holdings Ltd.Hutchison Chi-MedHutchison China MediTech LtdLi Ka-shing

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.